Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Bluebird Bio (BLUE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Latest Headlines for [[ item.sessionDateDisplayLong ]]
bluebird's Lenti-D Gets Breakthrough Therapy Status From FDA

bluebird (BLUE) obtained Breakthrough Therapy designation from the FDA for Lenti-D for the treatment of patients with cerebral adrenoleukodystrophy, which should expedite its development.

CELG : 79.54 (+2.42%)
BLUE : 187.00 (-1.27%)
NVS : 76.17 (-0.34%)
GILD : 67.53 (-0.94%)
Should Vanguard Russell 2000 Value ETF (VTWV) Be on Your Investing Radar?

Style Box ETF report for VTWV

IWN : 131.27 (-0.08%)
MTG : 10.61 (-0.47%)
VTWV : 114.14 (+0.03%)
BLUE : 187.00 (-1.27%)
VBR : 135.95 (+0.10%)
STL : 24.80 (+0.20%)
Victory Living Programs to Host 8th Annual Black & Blue Dine Around Event at Blue Martini and The Capital Grille in Fort Lauderdale

For the eighth consecutive year, Victory Living Programs invites members of the community to enjoy a one-of-a-kind dining experience that will tantalize your taste buds and support individuals with developmental...

BLUE : 187.00 (-1.27%)
bluebird bio to Present New Data from LentiGlobin(TM) Transfusion-Dependent B-Thalassemia and Severe Sickle Cell Disease Clinical Studies at Annual Congress of the European Hematology Association

--- Oral presentation of interim data from patients treated with updated study protocol of Phase 1 HGB-206 study of LentiGlobin in patients with severe sickle cell disease (SCD) -

BLUE : 187.00 (-1.27%)
bluebird bio to Present at Investor Conferences in May

bluebird bio, Inc. (Nasdaq: BLUE) today announced that members of the management team will present at the following upcoming investor conferences:

BLUE : 187.00 (-1.27%)
DB : 12.25 (-4.89%)
Technical Snapshots for These Biotech Stocks -- BioPharmX, bluebird bio, Calithera Biosciences, and Capricor Therapeutics

If you want a free Stock Review on BPMX, BLUE, CALA, and CAPR sign up now at www.wallstequities.com/registration. Pre-market, WallStEquities.com draws investors' attention to BioPharmX Corp. (NYSE AMER:...

BLUE : 187.00 (-1.27%)
BPMX : 0.22 (unch)
CALA : 5.40 (+3.85%)
CAPR : 1.35 (+0.75%)
Celgene (CELG) Q1 Earnings & Sales Beat on Revlimid Strength

Celgene (CELG) surpasses both earnings and sales estimates in the first quarter on the back of impressive performance from Pomalyst and Otezla.

CELG : 79.54 (+2.42%)
BLUE : 187.00 (-1.27%)
PRTA : 14.86 (+3.77%)
GILD : 67.53 (-0.94%)
bluebird bio Reports First Quarter 2018 Financial Results and Highlights Operational Progress

--- Entered into co-development and co-promotion agreement for bb2121 with Celgene -

BLUE : 187.00 (-1.27%)
Can Celgene (CELG) Keep Its Earnings Streak Alive in Q1?

Celgene (CELG) is likely to maintain momentum in the first quarter on the strength of its lead drug, Revlimid despite recent failures.

CELG : 79.54 (+2.42%)
BLUE : 187.00 (-1.27%)
RHHBY : 27.6200 (+0.29%)
VNDA : 17.20 (+1.78%)
After Yesterday's Decline of 1.41%, Bluebird Bio Inc Offers Investors Better Value

Bluebird Bio Inc (NASDAQ:BLUE) traded in a range yesterday that spanned from a low of $167.00 to a high of $172.99. Yesterday, the shares fell 1.4%, which took the trading range below the 3-day low of...

BLUE : 187.00 (-1.27%)
bluebird bio to Present at Alliance for Regenerative Medicine's 6th Annual Cell & Gene Therapy Investor Day

bluebird bio, Inc. (Nasdaq:BLUE) today announced that members of the management team will present at Alliance for Regenerative Medicine's 6th Annual Cell & Gene Therapy Investor Day on Tuesday,...

BLUE : 187.00 (-1.27%)
SmarTrend Watching for Potential Pullback in Shares of Bluebird Bio Inc After 7.56% Gain

Bluebird Bio Inc (NASDAQ:BLUE) traded in a range yesterday that spanned from a low of $167.40 to a high of $175.55. Yesterday, the shares gained 7.6%, which took the trading range above the 3-day high...

BLUE : 187.00 (-1.27%)
Notable Friday Option Activity: BLUE, SNBR, FC

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in bluebird bio Inc , where a total volume of 5,086 contracts has been traded thus far...

BLUE : 187.00 (-1.27%)
Shares of BLUE Down 21.4% Since Downtrend Call on Shares

SmarTrend identified a Downtrend for Bluebird Bio Inc (NASDAQ:BLUE) on March 16th, 2018 at $205.02. In approximately 3 weeks, Bluebird Bio Inc has returned 21.41% as of today's recent price of $161.13....

BLUE : 187.00 (-1.27%)
SmarTrend Watching for Potential Rebound in Shares of Bluebird Bio Inc After 1.08% Loss

Bluebird Bio Inc (NASDAQ:BLUE) traded in a range yesterday that spanned from a low of $158.50 to a high of $165.16. Yesterday, the shares fell 1.1%, which took the trading range below the 3-day low of...

BLUE : 187.00 (-1.27%)
Celgene (CELG) President and COO to Step Down: What's Ahead?

Celgene's (CELG) president and chief operating officer, Scott A. Smith, has decided to step down from his position with immediate effect further adding to the company's woes.

CELG : 79.54 (+2.42%)
BLUE : 187.00 (-1.27%)
RHHBY : 27.6200 (+0.29%)
REGN : 294.61 (-0.24%)
Celgene (CELG) Up on Deal With bluebird For CAR-T Candidate

Celgene's (CELG) stock was up by 3% after the company announced a co-promotion agreement with bluebird bio for one of its leading CAR-T candidates.

CELG : 79.54 (+2.42%)
BLUE : 187.00 (-1.27%)
RHHBY : 27.6200 (+0.29%)
REGN : 294.61 (-0.24%)
bluebird bio and Celgene Corporation Enter into Agreement to Co-Develop and Co-Promote Anti-BCMA CAR T Cell Therapy bb2121 in the United States

--- bluebird to receive milestones and royalties on ex-U.S. sales -

CELG : 79.54 (+2.42%)
BLUE : 187.00 (-1.27%)
CELGZ : 0.29 (+16.00%)
Bluebird Bio Inc Falls 4.26% on Heavy Volume: Watch For Potential Rebound

Bluebird Bio Inc (NASDAQ:BLUE) traded in a range yesterday that spanned from a low of $179.80 to a high of $190.13. Yesterday, the shares fell 4.3%, which took the trading range below the 3-day low of...

BLUE : 187.00 (-1.27%)
THC : 33.70 (+1.66%)
Best Relative Performance in the Biotechnology Industry Detected in Shares of Bluebird Bio Inc (BLUE , FPRX , HRTX , ATRA , STML )

Below are the top five companies in the Biotechnology industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that have the...

FPRX : 18.41 (+0.05%)
BLUE : 187.00 (-1.27%)
HRTX : 30.90 (-0.32%)

Van Meerten Stock Picks

5 Great Growth Stocks
This morning I wanted to find 5 stocks that were predicted to have double digit growth in both Revenue and Earnings over the next 5 years that were also having great current performance.
LULU +1.14 , ABMD -1.06 , AAXN +2.28 , NSP +0.90 , ERI +1.00
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.
Free Commodities Newsletter

Get prepared for your trading day with

Barchart's Commodity Futures Morning Update Email

InsideFutures Commentary

InsideFutures weekly newsletter features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Friday morning to your inbox.

Brugler Ag Report

Today's Commentary

Corn futures were weak into the close on Thursday, down 3 to 4 1/4 cents lower in the front months. Traders were taking money off the table ahead of the extended weekend. The USDA reported a private cancelation of 132,000 of grain sorghum to unknown ...
Read More

Alan Brugler writes this daily agricultural markets overview with opening, midday and closing comments directed at the gain and meat Ag markets.

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.

Free Barchart Webinar